NCT06093516 (ARUTIS) is a NA clinical trial of Tinted Lenses in Visual Stress, sponsored by Anglia Ruskin University.

Who is sponsoring NCT06093516?

NCT06093516 is sponsored by Anglia Ruskin University.

What drugs are being tested in NCT06093516?

Interventions in NCT06093516: Tinted Lenses.

What condition does NCT06093516 study?

NCT06093516 studies Visual Stress.

Is NCT06093516 still recruiting?

NCT06093516 is currently status unknown. Last updated 23 October 2023.

Last reviewed 2023-10-23 · How we verify

NCT06093516: ARUTIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The ARUTIS Study (Anglia Ruskin University Trial of the Intuitive System)

Status unknown NA Last updated 23 October 2023

What this trial tests

NA trial testing Tinted Lenses in Visual Stress in 120 participants. Status unknown.

Timeline

30 October 2023

Primary endpoint
1 September 2024

1 September 2024

Quick facts

Lead sponsor	Anglia Ruskin University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	120
Start date	30 October 2023
Primary completion	1 September 2024
Estimated completion	1 September 2024
Sites	1 location across United Kingdom

Drugs / interventions tested

Tinted Lenses

Conditions studied

Visual Stress — all drugs for Visual Stress →

Sponsor

Anglia Ruskin University

Who can join

Adults 9 to 18, any sex, with Visual Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this double-masked randomised controlled trial (RCT) is to assess the symptoms of visual stress (VS), reading speed and changes in behaviour / academic performance, when wearing optimal Precision Tinted Lenses compared to sub-optimal Precision Tinted Lenses (PTLs). In participants ages 9-18 years. Participants, parents and researchers will be masked until the end of the trial. Participants will be randomised into two groups A and B. 50% of participants will receive the optimal PTL where the other 50% will receive the sub-optimal PTL. Participants will be asked to wear the PTLs for one month. Followed by one month of no wear. After which, participants will receive the second pair of PTLs to wear for one month. Participants will need to fill out a symptom dairy everyday from the day of recruitment until the end of the trial. A symptom questionnaire will need to be filled out as baseline at recruitment and the end of each month of wear. An academic behaviour survey will also need to be filled out at baseline by parents and teachers at recruitment and the end of each month of wear. At the end of the three months unmasking will occur and participants will be given the PTL that demonstrate the greatest reduction in VS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The ARUTIS Study (Anglia Ruskin University Trial of the Intuitive System): a single-centre, double-masked randomised controlled crossover trial of precision tinted lenses for visual stress: study protocol for a randomised controlled trial.
Ramsahye ZN, Allen PM, Thomas NJ, Wilkins AJ, et al · · 2025 · PMID 41402843 · DOI 10.1186/s13063-025-09305-8

Verify or expand the search:

Other Anglia Ruskin University trials

Trials by the same sponsor.

NCT07161570 — Virtual Reality Digital Therapeutics for Seasonal Affective Disorder · NA · not yet recruiting
NCT07008586 — The Impact of OliPhenolia® Supplementation on Exercise Induced Inflammation and Functional Movement in Humans. · NA · completed
NCT07210099 — The Effect of Short-term Supplementation of OliPhenolia® on Fat Oxidation · NA · recruiting
NCT06844396 — The Impact of NICU Music Therapy for Preterm Infants and Caregivers · NA · completed
NCT07497113 — The Effects of Commercially Available High Protein Drink on Amino Acid Bioavailability and Recovery From Muscle Fatiguin · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06093516 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anglia Ruskin University
Last refreshed: 23 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06093516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing